Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Association of Cardiometa… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Association of Cardiometabolic Multimorbidity With Mortality

Artikel i vetenskaplig tidskrift
Författare E. Di Angelantonio
S. Kaptoge
D. Wormser
P. Willeit
A. S. Butterworth
N. Bansal
L. M. O'Keeffe
P. Gao
A. M. Wood
S. Burgess
D. F. Freitag
L. Pennells
S. A. Peters
C. L. Hart
L. L. Haheim
R. F. Gillum
B. G. Nordestgaard
B. M. Psaty
B. B. Yeap
M. W. Knuiman
P. J. Nietert
J. Kauhanen
J. T. Salonen
L. H. Kuller
L. A. Simons
Y. T. van der Schouw
E. Barrett-Connor
R. Selmer
C. J. Crespo
B. Rodriguez
W. M. Verschuren
V. Salomaa
K. Svardsudd
P. van der Harst
Cecilia Björkelund
Lars Wilhelmsen
R. B. Wallace
H. Brenner
P. Amouyel
E. L. Barr
H. Iso
A. Onat
M. Trevisan
R. B., Sr. D'Agostino
C. Cooper
M. Kavousi
Lennart Welin
R. Roussel
F. B. Hu
S. Sato
K. W. Davidson
B. V. Howard
M. J. Leening
Annika Rosengren
M. Dorr
D. J. Deeg
S. Kiechl
C. D. Stehouwer
A. Nissinen
S. Giampaoli
C. Donfrancesco
D. Kromhout
J. F. Price
A. Peters
T. W. Meade
E. Casiglia
D. A. Lawlor
J. Gallacher
D. Nagel
O. H. Franco
G. Assmann
G. R. Dagenais
J. W. Jukema
J. Sundstrom
M. Woodward
E. J. Brunner
K. T. Khaw
N. J. Wareham
E. A. Whitsel
I. Njolstad
B. Hedblad
S. Wassertheil-Smoller
G. Engstrom
W. D. Rosamond
E. Selvin
N. Sattar
S. G. Thompson
J. Danesh
Publicerad i JAMA
Volym 314
Nummer/häfte 1
Sidor 52-60
ISSN 0098-7484
Publiceringsår 2015
Publicerad vid Institutionen för medicin
Institutionen för medicin, avdelningen för molekylär och klinisk medicin
Sidor 52-60
Språk en
Länkar dx.doi.org/10.1001/jama.2015.7008
Ämnesord Adult, Aged, Comorbidity, *Diabetes Mellitus/epidemiology, Female, Humans, *Life Expectancy, Male, Middle Aged, *Mortality, *Myocardial Infarction/epidemiology, Risk Factors, *Stroke/epidemiology
Ämneskategorier Allmän medicin

Sammanfattning

IMPORTANCE: The prevalence of cardiometabolic multimorbidity is increasing. OBJECTIVE: To estimate reductions in life expectancy associated with cardiometabolic multimorbidity. DESIGN, SETTING, AND PARTICIPANTS: Age- and sex-adjusted mortality rates and hazard ratios (HRs) were calculated using individual participant data from the Emerging Risk Factors Collaboration (689,300 participants; 91 cohorts; years of baseline surveys: 1960-2007; latest mortality follow-up: April 2013; 128,843 deaths). The HRs from the Emerging Risk Factors Collaboration were compared with those from the UK Biobank (499,808 participants; years of baseline surveys: 2006-2010; latest mortality follow-up: November 2013; 7995 deaths). Cumulative survival was estimated by applying calculated age-specific HRs for mortality to contemporary US age-specific death rates. EXPOSURES: A history of 2 or more of the following: diabetes mellitus, stroke, myocardial infarction (MI). MAIN OUTCOMES AND MEASURES: All-cause mortality and estimated reductions in life expectancy. RESULTS: In participants in the Emerging Risk Factors Collaboration without a history of diabetes, stroke, or MI at baseline (reference group), the all-cause mortality rate adjusted to the age of 60 years was 6.8 per 1000 person-years. Mortality rates per 1000 person-years were 15.6 in participants with a history of diabetes, 16.1 in those with stroke, 16.8 in those with MI, 32.0 in those with both diabetes and MI, 32.5 in those with both diabetes and stroke, 32.8 in those with both stroke and MI, and 59.5 in those with diabetes, stroke, and MI. Compared with the reference group, the HRs for all-cause mortality were 1.9 (95% CI, 1.8-2.0) in participants with a history of diabetes, 2.1 (95% CI, 2.0-2.2) in those with stroke, 2.0 (95% CI, 1.9-2.2) in those with MI, 3.7 (95% CI, 3.3-4.1) in those with both diabetes and MI, 3.8 (95% CI, 3.5-4.2) in those with both diabetes and stroke, 3.5 (95% CI, 3.1-4.0) in those with both stroke and MI, and 6.9 (95% CI, 5.7-8.3) in those with diabetes, stroke, and MI. The HRs from the Emerging Risk Factors Collaboration were similar to those from the more recently recruited UK Biobank. The HRs were little changed after further adjustment for markers of established intermediate pathways (eg, levels of lipids and blood pressure) and lifestyle factors (eg, smoking, diet). At the age of 60 years, a history of any 2 of these conditions was associated with 12 years of reduced life expectancy and a history of all 3 of these conditions was associated with 15 years of reduced life expectancy. CONCLUSIONS AND RELEVANCE: Mortality associated with a history of diabetes, stroke, or MI was similar for each condition. Because any combination of these conditions was associated with multiplicative mortality risk, life expectancy was substantially lower in people with multimorbidity.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?